Content about Law

“Drugs don’t work in patients who don’t take them.”

Sounds simple enough. But that obvious truism, voiced by former U.S. surgeon general C. Everett Koop, fails to convince tens of millions of patients that they should take their prescription medicines through the full dosage regimen. And in too many cases, patients aren’t even filling the script to begin with.

GRAND RAPIDS, Mich. — Meijer is preparing to hire thousands of new employees for its stores as it prepares for this year's holiday season and continued growth throughout the Midwest.

"Customer service is one of the things that truly sets Meijer apart from our competition," Meijer EVP operations Janet Emerson said. "Our goal is to deliver the best customer experience and the lowest prices, and as we continue to grow it's so important that we have the right levels of staff and the right people in those roles."

PLEASANTON, Calif. — Safeway has launched a personal call to action that directly involves and rewards employees and shoppers.

The "Heart of Safeway Pledge" extends the retailer's corporate social responsibility commitment and invites employees and shoppers to take simple, everyday steps — such as using energy-conserving light bulbs, taking a 15-minute walk three times a week or eating healthier foods — to benefit people and their communities.

LAKELAND, Fla. — Publix on Monday announced its board of directors declared a semi-annual dividend on its common stock of 30 cents per share. The dividend will be payable and mailed Dec. 3, 2012, to stockholders of record as of the close of business Oct. 31, 2012.

ZUSA, Calif. and CITY OF INDUSTRY, Calif. — Physicians Formula and Markwins International announced on Thursday that they have entered into a merger agreement under which Markwins will acquire all of the outstanding shares of common stock of Physicians Formula for $4.90 per share in cash, or approximately $74.9 million.

In June, Walgreens announced a two-step investment in a strategic partnership with Alliance Boots, to acquire a 45% equity stake in the privately held company for $6.7 billion in cash and stock in the first step with the option to acquire the other 55% approximately three years down the road at what is today being projected to be another $9.5 billion price tag in cash and stock. 


Patients diagnosed with serious disease have enough on their minds. So Walgreens is doing all it can to make it easier for them to obtain, administer and pay for their specialty and infused medicines, said Mike Ellis, VP specialty pharmacy and infusion.


“The concept is to go where patients are diagnosed and where they reside. We have a large sales force who call on physicians who prescribe these types of medications. But like everything else at Walgreens, it starts with the patient.”


The way Walgreens is deploying technology through its stores may be futuristic, but it is no science fiction. It’s real innovation that is helping to drive its total transformation along so many areas of its business — and it’s being produced in real-time.

Walgreens is fundamentally changing the way it does business with both its upstream pharmaceutical suppliers and its downstream customers in the managed care world. The goal: to help its partners on both ends knock down decision-making silos and create more strategic and profitable relationships that lead to lower costs, higher profits and most importantly, healthier patients.


ARLINGTON, Va. — More than three-quarters of physicians think the federal government should regulate foods with unhealthy ingredients, while 79% say employers should fund weight-loss programs for employees, according to results of a survey presented Tuesday at a diabetes conference.

The survey, conducted by Joslin Diabetes Center and healthcare research firm WorldOne, included more than 150 endocrinologists and primary care physicians, and results were presented at Joslin's Diabetes Innovation 2012 conference.

For the more than 100 years that Walgreens has been in operation, the company has been focused on helping its customers, communities and patients feel well. And now, it is poised to transform the traditional drug store into a health and daily living destination. 


PHOENIX — The Arizona Corporate Excellence Awards has named Avella Specialty Pharmacy as the fastest-growing private company based in the state, Avella said.

Avella, formerly known as The Apothecary Shops, received the award from the Phoenix Business Journal. The ACE Awards recognize private companies based on the growth of their business, innovation, community involvement, dedication to employees and leadership accomplishments. The company changed its name to Avella in July.